# German firms face mixed market signals > Live situation record from CLSTR: https://clstr.news/situations/redcare-pharmacy-stock-outlook > Updated: 2026-07-28T12:14:14.000Z. Sources: 18. Developments: 9. After a period of tightening valuations and earnings uncertainty that saw Redcare’s rebound, BMW’s profit warning and downgrades of Henkel, German equities remained under pressure through late June. UBS kept a neutral view on Henkel ahead of its August earnings, while analysts highlighted discount valuations relative to peers. The tone shifted on 26 June when Deutsche Bank Research lifted its price target on Henkel to €76 and maintained a "buy" rating, pointing to the company’s strong brand portfolio, resilient adhesives business and tighter cost management despite inflationary headwinds. At the same time, Porsche AG recorded the top position in JD Power’s 2026 U.S. Initial Quality Study, with the 911 model winning both overall and premium sport‑car categories for a second year. The quality accolade helped Porsche’s shares climb about 2 % to €43.22, offering a positive contrast to the broader market slump. Further optimism surfaced on 2 July when JPMorgan retained Overweight ratings on two German companies. Auto1, the online used‑car marketplace, kept its €37 target price as the bank forecast 2027 sales volumes roughly 23 % above consensus, emphasizing the platform’s scaling potential. Nemetschek, a construction‑software specialist, also remained Overweight with a €110 target price, driven by AI initiatives, a broad software portfolio and possible M&A activity. The bullish stance continued on 7 July as JPMorgan reaffirmed its Overweight view on Siemens Energy, citing the upcoming 2027 reform of Germany’s Renewable Energy Act as a catalyst for wind‑power and energy‑network segments. Analyst coverage remained mixed in late July. JPMorgan left its rating on German brake‑system maker Knorr‑Bremse unchanged at Neutral with a €108 target, noting Q2 revenue and EBIT 4 % above consensus but conservative 2030 goals. ## Timeline ### 2026-07-28: Knorr‑Bremse, Renault, Airbus retain stable analyst ratings JPMorgan, Bernstein, and Jefferies keep their Neutral, Outperform, and Hold ratings on Knorr‑Bremse, Renault, and Airbus respectively, citing solid recent earnings and modest target prices. 4 sources. https://clstr.news/cluster/jpmorgan-rates-safran-and-munich-re-overweight ### 2026-07-07: JPMorgan keeps Saint‑Gobain and Siemens Energy at Overweight JPMorgan kept Saint‑Gobain and Siemens Energy at Overweight, citing better margins for the former and upcoming German EEG reforms for the latter. 3 sources. https://clstr.news/cluster/jpmorgan-keeps-saintgobain-and-siemens-energy-at-overweight ### 2026-07-02: JPMorgan Maintains Overweight Ratings for Auto1 and Nemetschek JPMorgan kept Overweight ratings for German firms Auto1 (target €37) and Nemetschek (target €110), citing volume growth, AI prospects and M&A potential. 2 sources. https://clstr.news/cluster/jpmorgan-maintains-overweight-ratings-for-auto1-and-nemetschek ### 2026-06-26: German firms Henkel and Porsche gain upbeat market signals Deutsche Bank raised Henkel's target to €76, keeping a buy rating, while Porsche topped JD Power's 2026 U.S. quality study, boosting its stock by 2.3%. 2 sources. https://clstr.news/cluster/german-firms-henkel-and-porsche-gain-upbeat-market-signals ### 2026-06-23: UBS Keeps Henkel Rating Neutral with 71‑Euro Target UBS retains a neutral rating on Henkel, setting a 71‑euro target price and noting possible price‑driven surprise in the August 6 earnings, while comparing it to US rival H.B. Fuller. 2 sources. https://clstr.news/cluster/ubs-keeps-henkel-rating-neutral-with-71euro-target ### 2026-06-21: Henkel and BMW face downgraded outlooks amid market pressure JP Morgan rates Henkel's preferred share Underweight, and BMW halves its profit outlook due to a weak Chinese market, prompting cost‑cut talks while keeping dividends and buybacks. 2 sources. https://clstr.news/cluster/henkel-and-bmw-face-downgraded-outlooks-amid-market-pressure ### 2026-06-17: BMW warns of steep profit drop amid China slump and Middle‑East tension BMW cuts its 2026 profit outlook, blaming weak Chinese demand and Middle‑East tensions; shares fall over 7% to a 2020 low. 12 sources. https://clstr.news/cluster/berenberg-lifts-redcare-pharmacy-target-price-to-92-keeps-buy-rating ### 2026-06-15: Redcare Pharmacy rating upgrades and target price revisions Deutsche Bank lifted Redcare Pharmacy’s target to €102 (Buy) and UBS raised it to €60 (Neutral); ratings on Vinci, BMW and LVMH stayed unchanged. 5 sources. https://clstr.news/cluster/redcare-pharmacy-lifts-2024-revenue-forecast-to-1517-and-sees-shares-surge ### 2026-05-22: Redcare Pharmacy shares seen as undervalued as price steadies near €45.5 Redcare Pharmacy’s share price has steadied at €45.5, back to end‑2022 levels, with analysts labeling it undervalued and forecasting possible gains over 100 %. 2 sources. https://clstr.news/cluster/redcare-pharmacy-shares-seen-as-undervalued-as-price-steadies-near-455 --- Cite as: German firms face mixed market signals. CLSTR, https://clstr.news/situations/redcare-pharmacy-stock-outlook